Hennion & Walsh Asset Management, Inc. Kura Oncology, Inc. Transaction History
Hennion & Walsh Asset Management, Inc.
- $2.35 Billion
- Q2 2025
A detailed history of Hennion & Walsh Asset Management, Inc. transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Hennion & Walsh Asset Management, Inc. holds 185,930 shares of KURA stock, worth $1.12 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
185,930
Previous 119,816
55.18%
Holding current value
$1.12 Million
Previous $844,000
27.01%
% of portfolio
0.05%
Previous 0.04%
Shares
13 transactions
Others Institutions Holding KURA
# of Institutions
188Shares Held
79.1MCall Options Held
76KPut Options Held
85.8K-
Bvf Inc San Francisco, CA7.75MShares$46.8 Million2.25% of portfolio
-
Suvretta Capital Management, LLC New York, NY7.44MShares$44.9 Million2.15% of portfolio
-
Black Rock Inc. New York, NY6.97MShares$42 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY6.57MShares$39.6 Million0.66% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.95MShares$29.8 Million0.0% of portfolio
About Kura Oncology, Inc.
- Ticker KURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,893,000
- Market Cap $403M
- Description
- Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...